PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2017.3562018503894-907Participation of CCL1 in Snail-Positive Fibroblasts in Colorectal Cancer Contribute to 5-Fluorouracil/Paclitaxel ChemoresistanceZiqian Li, Kaying Chan, Yifei Qi, Linlin Lu, Fen Ning, Mengling Wu, Haifang Wang, Yuan Wang, Shaohui Cai, Jun Duhttp://e-crt.org/upload/pdf/crt-2017-356.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2017.356, http://www.e-crt.org/upload/pdf/crt-2017-356.pdf
Gastroenterology10.1016/s0016-5085(15)33253-420151484S-953Tu1987 microRNA-150 As a Chemoresistance Factor to 5-Fluorouracil Inhibit Proliferation and Apoptosis in Colorectal CancerJun Haohttps://api.elsevier.com/content/article/PII:S0016508515332534?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508515332534?httpAccept=text/plain
Carcinogenesis10.1093/carcin/bgab0272021426814-825Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancerYinghui Zhao, Chuanxin Wang, Ajay Goelhttp://academic.oup.com/carcin/advance-article-pdf/doi/10.1093/carcin/bgab027/38496503/bgab027.pdf, http://academic.oup.com/carcin/article-pdf/42/6/814/38711329/bgab027.pdf, http://academic.oup.com/carcin/article-pdf/42/6/814/38711329/bgab027.pdf
Clinical Colorectal Cancer10.1016/j.clcc.2018.10.006201918158-635-Fluorouracil-related Cardiotoxicity; Findings From Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal CancerOmar Abdel-Rahmanhttps://api.elsevier.com/content/article/PII:S1533002818304626?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002818304626?httpAccept=text/plain
Clinical Colorectal Cancer10.1016/s1533-0028(11)70502-320022151-52Inhibiting 5-Fluorouracil Breakdown: A Broken Down Approach to 5-Fluorouracil ModulationRichard L. Schilskyhttps://api.elsevier.com/content/article/PII:S1533002811705023?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002811705023?httpAccept=text/plain
Clinical Colorectal Cancer10.3816/ccc.2007.n.029200769609Clinical Colorectal Cancer: “Ode to 5-Fluorouracil”Edward Chuhttps://api.elsevier.com/content/article/PII:S1533002811702997?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002811702997?httpAccept=text/plain
PLOS ONE10.1371/journal.pone.01256252015105e0125625Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal CancerYibing Hu, Chang Yan, Lei Mu, Kaiyu Huang, Xiaolan Li, Deding Tao, Yaqun Wu, Jichao Qinhttp://dx.plos.org/10.1371/journal.pone.0125625
Annals of Oncology10.1016/s0923-7534(21)00373-2201627ix66215P 53BP1 loss induces the chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting ATM-CHK2-P53 pathwayH. Ma, J. Yao, A. Huang, T. Zhanghttps://api.elsevier.com/content/article/PII:S0923753421003732?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753421003732?httpAccept=text/plain
Clinical Colorectal Cancer10.1016/s1533-0028(11)70512-6200222102-103Irinotecan in 5-Fluorouracil—Refractory Colorectal CancerRomano Danesi, Antonello Di Paolohttps://api.elsevier.com/content/article/PII:S1533002811705126?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002811705126?httpAccept=text/plain
Clinical Colorectal Cancer10.1016/s1533-0028(11)70503-520022153Can Eniluracil Improve 5-Fluorouracil Therapy?Robert B. Diasiohttps://api.elsevier.com/content/article/PII:S1533002811705035?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002811705035?httpAccept=text/plain